Lukas Biomedical Inc. (TPEX:6814)

Lukas Biomedical Revenue

Lukas Biomedical had revenue of 91.58M TWD in the half year ending December 31, 2025, a decrease of -22.10%. This brings the company's revenue in the last twelve months to 170.01M, down -5.72% year-over-year. In the year 2025, Lukas Biomedical had annual revenue of 179.49M, down -5.44%.

• Revenue (ttm): 170.01M
• Revenue Growth: -5.72%
• P/S Ratio: 5.30
• Revenue / Employee: n/a
• Employees: 87
• Market Cap: 900.30M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	179.49M	-10.34M	-5.44%
Dec 31, 2024	189.83M	-42.01M	-18.12%
Dec 31, 2023	231.83M	47.05M	25.46%
Dec 31, 2022	184.79M	27.17M	17.24%
Dec 31, 2021	157.62M	-23.79M	-13.12%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 26, 2026

Data Sources Report a data error